Lymphocytotix antibodies in subacute sclerosing panencephalitis and amyotrophic lateral sclerosis

CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.

Mucosal immunology·2018

Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.

Multiple sclerosis and related disorders·2018

Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.

Experimental neurology·2014

The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis.

AJNR. American journal of neuroradiology·2012

Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Neurology·2012

Demographic and clinical characteristics of malignant multiple sclerosis.

Neurology·2011

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Clinical Practice of Single-Molecule Real-Time Sequencing in the Diagnosis of Spinal Muscular Atrophy.

Molecular genetics & genomic medicine·2026

Astrocytic cathepsin D promotes α-synuclein processing and Lewy neurite-like aggregate maturation.

EMBO reports·2026

Long-term clinical and biomarker observations following rituximab exposure in two siblings with CSF1R-related leukoencephalopathy: a preliminary familial case series.

Communications medicine·2026

What can narcolepsy teach us about hypocretin and dementia?

Ageing research reviews·2026

Estradiol Attenuates Cardiac Apoptosis and Modulates Cardiovascular Remodeling in Ovariectomized Female Rats with 6-Hydroxydopamine-Induced Parkinsonism.

Physiology & behavior·2026

Related Experiment Videos

Lymphocytotix antibodies in subacute sclerosing panencephalitis and amyotrophic lateral sclerosis

Related Concept Videos

CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.

Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.

Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.

The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis.

Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Demographic and clinical characteristics of malignant multiple sclerosis.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Clinical Practice of Single-Molecule Real-Time Sequencing in the Diagnosis of Spinal Muscular Atrophy.

Astrocytic cathepsin D promotes α-synuclein processing and Lewy neurite-like aggregate maturation.

Long-term clinical and biomarker observations following rituximab exposure in two siblings with CSF1R-related leukoencephalopathy: a preliminary familial case series.

What can narcolepsy teach us about hypocretin and dementia?

Estradiol Attenuates Cardiac Apoptosis and Modulates Cardiovascular Remodeling in Ovariectomized Female Rats with 6-Hydroxydopamine-Induced Parkinsonism.

Related Experiment Videos

Lymphocytotix antibodies in subacute sclerosing panencephalitis and amyotrophic lateral sclerosis

Related Concept Videos

Related Articles